These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9660996)

  • 1. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.
    Ardanuy C; Liñares J; Domínguez MA; Hernández-Allés S; Benedí VJ; Martínez-Martínez L
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1636-40. PubMed ID: 9660996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
    Shi W; Li K; Ji Y; Jiang Q; Wang Y; Shi M; Mi Z
    Braz J Microbiol; 2013; 44(2):435-42. PubMed ID: 24294234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.
    Martínez-Martínez L; Pascual A; Hernández-Allés S; Alvarez-Díaz D; Suárez AI; Tran J; Benedí VJ; Jacoby GA
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1669-73. PubMed ID: 10390220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.
    Martínez-Martínez L; Hernández-Allés S; Albertí S; Tomás JM; Benedi VJ; Jacoby GA
    Antimicrob Agents Chemother; 1996 Feb; 40(2):342-8. PubMed ID: 8834877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outer membrane protein profiles of clonally related Klebsiella pneumoniae isolates that differ in cefoxitin resistance.
    Skopková-Zarnayová M; Siebor E; Rovná D; Bujdáková H; Neuwirth C
    FEMS Microbiol Lett; 2005 Feb; 243(1):197-203. PubMed ID: 15668019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
    Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems.
    Crowley B; Benedí VJ; Doménech-Sánchez A
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3679-82. PubMed ID: 12384391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.
    Kaczmarek FM; Dib-Hajj F; Shang W; Gootz TD
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3396-406. PubMed ID: 17005822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of association of OmpK35 and OmpK36 alteration and bla
    Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
    Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.
    Gröbner S; Linke D; Schütz W; Fladerer C; Madlung J; Autenrieth IB; Witte W; Pfeifer Y
    J Med Microbiol; 2009 Jul; 58(Pt 7):912-922. PubMed ID: 19502377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
    Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
    J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.
    Chudácková E; Bergerová T; Fajfrlík K; Cervená D; Urbásková P; Empel J; Gniadkowski M; Hrabák J
    FEMS Microbiol Lett; 2010 Aug; 309(1):62-70. PubMed ID: 20528936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
    J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
    J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
    Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
    J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of CTX-M-15 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in Bosnia and Herzegovina.
    Dedeic-Ljubovic A; Hukic M; Pfeifer Y; Witte W; Padilla E; López-Ramis I; Albertí S
    Clin Microbiol Infect; 2010 Feb; 16(2):152-6. PubMed ID: 19686282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae.
    Cremanns M; Lange F; Gatermann SG; Pfennigwerth N
    J Antimicrob Chemother; 2022 May; 77(6):1578-1585. PubMed ID: 35265984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.
    Cubero M; Cuervo G; Dominguez MÁ; Tubau F; Martí S; Sevillano E; Gallego L; Ayats J; Peña C; Pujol M; Liñares J; Ardanuy C
    BMC Microbiol; 2015 Sep; 15():177. PubMed ID: 26335352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.